With the rise and deepening of glutamine metabolism research, SLC1A5 (ASCT2) has gradually become known as the main glutamine transporter, and increasing evidence has shown that SLC1A5 plays important roles in tumour metastasis. Here, SLC1A5 is linked to neoplasm.